Content

Welcome to the CJU website » LOG IN

April 2014 ( Volume 21, Supplement 1 )




  1. INTRODUCTION - Current management of advanced and castration resistant prostate cancer
    Leonard G. Gomella, MD, Daniel P. Petrylak, MD, Bobby Shayegan, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 1 - 6)
  1. The changing landscape of advanced and castration resistant prostate cancer: latest science and revised definitions
    Derya Tilki, MD, Christopher P. Evans, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 7 - 13)
  1. Traditional androgen ablation approaches to advanced prostate cancer: new insights
    Kyle O. Rove, MD, E. David Crawford, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 14 - 21)
  1. Utility of LHRH antagonists for advanced prostate cancer
    Judd W. Moul, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Issue 1, Pages 22 - 27)
  1. Intermittent androgen deprivation therapy for prostate cancer: translating randomized controlled trials into clinical practice
    Shawn Dason, MD, Christopher Brian Allard, MD, Jing Gennie Wang, MD(c), Jen Hoogenes, MS, Bobby Shayegan, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 28 - 36)
  1. Secondary hormonal manipulation in castration resistant prostate
    Sohaib Al-Asaaed, MD, Eric Winquist, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 37 - 41)
  1. Imaging approaches with advanced prostate cancer: techniques and timing
    David Leung, MD, Saravanan Krishnamoorthy, MD, Lawrence Schwartz, MD, Chaitanya Divgi, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Issue 1, Pages 42 - 47)
  1. Practical guide to immunotherapy in castration resistant prostate cancer: the use of sipuleucel-T immunotherapy
    Leonard G. Gomella, MD, Francisco Gelpi-Hammerschmidt, MD, Chandan Kundavaram, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 48 - 56)
  1. Practical guide to the use of abiraterone in castration resistant prostate cancer
    Elahe A. Mostaghel, MD, Daniel W. Lin, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Issue 1, Pages 57 - 63)
  1. Practical guide to the use of enzalutamide
    Jean Hoffman-Censits, MD, Wm. Kevin Kelly, DO
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 64 - 69)
  1. Practical guide to the use of radium 223 dichloride
    Robert B. Den, MD, Laura A. Doyle, MS, Karen E. Knudsen, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 70 - 76)
  1. Practical guide to the use of chemotherapy in castration resistant prostate cancer
    Daniel P. Petrylak, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 77 - 83)
  1. Practical guide to bone health in the spectrum of advanced prostate cancer
    Valentina Butoescu, MD, Bertrand Tombal, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 84 - 92)
  1. How to approach sequencing therapy in patients with metastatic castration resistant prostate cancer
    Robert Dreicer, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 93 - 97)
  1. Emerging therapies in castration resistant prostate cancer
    Gregory R. Thoreson, MD, Bishoy A. Gayed, MD, Paul H. Chung MD, Ganesh V. Raj, MD
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages 98 - 105)
  1. POST-TEST FOR CME
    The Canadian Journal of Urology
    April 2014 (Volume 21, Supplement 1, Pages A11 - A14)

Current Issue

Apr 2017, Vol.24 No.2
canadian journal of urology

mobile
canadian journal of urology